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Hu, Liping, Jude T. Deeney, Christopher J. Nolan, Marie-Line
Peyot, Ada Ao, Ann Marie Richard, Esthere Luc, Nils J. Faerge-
man, Jens Knudsen, Wen Guo, Maria Sorhede-Winzell, Marc
Prentki, and Barbara E. Corkey. Regulation of lipolytic activity by
long-chain acyl-coenzyme A in islets and adipocytes. Am J Physiol
Endocrinol Metab 289: E1085–E1092, 2005. First published August
9, 2005; doi:10.1152/ajpendo.00210.2005.—Intracellular lipolysis is
a major pathway of lipid metabolism that has roles, not only in the
provision of free fatty acids as energy substrate, but also in intracel-
lular signal transduction. The latter is likely to be particularly impor-
tant in the regulation of insulin secretion from islet -cells. The
mechanisms by which lipolysis is regulated in different tissues is,
therefore, of considerable interest. Here, the effects of long-chain
acyl-CoA esters (LC-CoA) on lipase activity in islets and adipocytes
were compared. Palmitoyl-CoA (Pal-CoA, 1–10 M) stimulated
lipase activity in islets from both normal and hormone-sensitive lipase
(HSL)-null mice and in phosphatase-treated islets, indicating that the
stimulatory effect was neither on HSL nor phosphorylation dependent.
In contrast, we reproduced the previously published observations
showing inhibition of HSL activity by LC-CoA in adipocytes. The
inhibitory effect of LC-CoA on adipocyte HSL was dependent on
phosphorylation and enhanced by acyl-CoA-binding protein (ACBP).
In contrast, the stimulatory effect on islet lipase activity was blocked
by ACBP, presumably due to binding and sequestration of LC-CoA.
These data suggest the following intertissue relationship between
islets and adipocytes with respect to fatty acid metabolism, LC-CoA
signaling, and lipolysis. Elevated LC-CoA in islets stimulates lipoly-
sis to generate a signal to increase insulin secretion, whereas elevated
LC-CoA in adipocytes inhibits lipolysis. Together, these opposite
actions of LC-CoA lower circulating fat by inhibiting its release from
adipocytes and promoting fat storage via insulin action.
acyl-coenzyme A-binding protein; free fatty acid; hormone-sensitive
lipase; lipid signaling
INTRACELLULAR LIPOLYSIS IS A MAJOR PATHWAY of lipid metabo-
lism, the function of which is highly tissue specific. Lipolysis
in the adipocyte has received the most attention, and it serves
the important role of releasing free fatty acids (FFA) from
adipose triglyceride (TG) stores into the circulation for whole
body energy provision at times of need such as during the
fasted state and exercise (20). Lipolysis in the pancreatic
-cell, however, has been proposed to have an important role
in providing FFA for the production of lipid-signaling mole-
cules important in the regulation of normal insulin secretion
(29, 33, 46). With such divergent roles between tissues, it is
likely that the lipase enzymes involved and the mechanisms
regulating lipolysis will be highly tissue specific.
Adipocyte lipolysis is highly regulated according to nutri-
tional status. Hormone-sensitive lipase (HSL, EC 3.1.1.3), an
acylglycerol lipase with broad substrate specificity, is believed
to be the key enzyme involved (16, 20), although there is
evidence that other lipases are also present in fat cells (30).
HSL in adipose tissue is activated by hormones such as
catecholamines, adrenocorticotropic hormone, and glucagon
via stimulating adenylate cyclase activity, which increases
cAMP (16, 20). The increased cAMP activates protein kinase
A (PKA) which, in turn, activates HSL activity by phosphor-
ylation (16, 20). Insulin inhibits HSL through phosphodiester-
ase-3-dependent cAMP degradation (16, 20). It has also been
proposed that long-chain acyl-CoA esters (LC-CoA) may have
a role in regulating lipases (18, 27, 39) and, in particular,
adipocyte HSL activity (18, 39).
The role of islet lipolysis in the regulation of normal insulin
secretion and the lipases involved is poorly understood. How-
ever, it is well established that FFA have important permissive
(9) and amplification roles (38) in insulin secretion and, if
chronically elevated, particularly in association with hypergly-
cemia, can induce -cell failure (11, 34). Both exogenous and
endogenous (from TG hydrolysis) sources of FFA are believed
to be involved. Of relevance to endogenous sources, it has been
demonstrated that inhibition of islet lipolysis by pharmacolog-
ical agents (26, 29, 46) and enhanced lipolysis by overexpres-
sion of HSL (22) both impair insulin secretion. Interestingly, a
-cell-specific isoform of HSL has been determined (22), but
experiments in HSL/ mice show that this enzyme is not
important (28), or important in only very specific circum-
stances (33), for normal glucose-stimulated insulin secretion.
Clearly, alternative lipase/s may have much more critical roles
in the islet (33). Elevated glucose has been shown to stimulate
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lipolysis in both rat (29) and mouse (33) islets, including
HSL/ mouse (33) islets. It is unknown whether LC-CoA can
modulate lipase activity in islets.
LC-CoA and their derivatives are regarded not only as
intermediates of lipid biosynthesis but also as potent regulators
of enzymes, ion channels, and various signal-transducing ef-
fectors (12). In -cells, LC-CoA esters activate ATP-sensitive
K (KATP) channels (2, 3, 15, 21), modulate intracellular Ca2
(8), activate atypical PKC isoforms (47), and directly stimulate
exocytosis resulting in insulin secretion (7). Of relevance to
lipolysis, previous studies document that 25 mol/l palmitoyl-
CoA (Pal-CoA) and 40 mol/l oleoyl-CoA inactivate lipase
activity half-maximally in pigeon adipose tissue, whereas 100
mol/l Pal-CoA reduces lipase activity by 90% (39). Perfusion
of rat hearts with 100 and 200 mol/l Pal-CoA reduces lipase
activity by 17 and 67%, respectively (27). HSL from bovine
perirenal adipose tissue is inhibited 50% by 0.1 mol/l oleoyl-
CoA (18).
It has been suggested that fatty acid-binding protein (FABP)
and acyl-CoA-binding protein (ACBP), with their high affinity
for LC-CoA, effectively buffer acyl-CoA concentrations. This
may play an important role in the metabolism and partitioning
of LC-CoA esters (43). It is well established that ACBP/LC-
CoA interactions can modulate activity of several microsomal
acyl-CoA-utilizing enzymes (36). ACBP can create an intra-
cellular acyl-CoA pool and shield acyl-CoA esters from acyl-
CoA hydrolases (19, 24). Furthermore, ACBP can protect
acetyl-CoA carboxylase from the inhibitory effects of acyl-
CoA esters (36). Of relevance to lipolysis, Bernlohr and Krae-
mer recently documented a protein-protein interaction between
HSL and FABP in vitro and in vivo and an increased HSL
activity with FABP addition (40, 42).
To better understand the role of LC-CoA in the regulation of
lipolysis, including HSL and non-HSL lipase activities, and in
signal transduction in adipocytes and islets, we assessed lipase
enzyme activities in various preparations of these tissues,
including HSL/ tissues, in the presence and absence of
Pal-CoA. The effects of interaction between Pal-CoA and
ACBP on lipase activities were also assessed. We found that
Pal-CoA markedly stimulated islet non-HSL lipase activity,
whereas it inhibited HSL in adipose tissue. ACBP enhanced
the inhibitory effect of Pal-CoA on HSL in adipocytes while
diminishing the stimulatory effect of Pal-CoA on islet lipase.
MATERIALS AND METHODS
Animals. Sprague-Dawley rats and C57BL/6 mice were purchased
from Charles River Laboratories. The animals were housed in the
Laboratory Animal Science Center at Boston University Medical
Center. HSL/ and HSL/ islets were obtained from mice gener-
ated by Mitchell and Prentki (33, 37, 44). The experimental protocols
were approved by the Institutional Animal Care and Use Committees
at Boston University Medical Center and the Centre Hospitalier de
l’Universite´ de Montre´al.
Materials. Purified bovine ACBP was a gift from Faergeman and
Knudsen (23). Collagenase P was from Roche. Pal-CoA, was from
Pharmacia. Palmitate, oleate, Phenyl-Sepharose CL-4B, protease in-
hibitor cocktail, phosphatase inhibitor cocktail, p-nitrophenyl bu-
tyrate (PNPB) (31), p-nitrophenol standard solution, ethylene glycol,
Hanks’ balanced salts, PKA, and protein phosphatase 2A (PP2A)
were from Sigma. 3-[(3-Cholamidopropyl)dimethylammonio]-1-pro-
panesulfonate (CHAPS) was from Fluka. Amicon ultrafilters were
from Millipore.
Isolation of mouse pancreatic islets and subcellular fractionation.
Islets from fed 3- to 5-mo-old male mice were isolated by collagenase
digestion of the total pancreas, as previously described (33). Islets
were handpicked under a stereomicroscope. At the end of the isolation
step, islets were cultured overnight at 37°C in a humidified atmo-
sphere (5% CO2-95% air) in RPMI 1640 medium supplemented with
24 mmol/l NaHCO3, 50 U/ml penicillin, 50 g/ml streptomycin, 0.03
mmol/l glutathione, 0.1 mol/l selenious acid, and 10% fetal calf
serum, pH 7.2. Islets were then washed and frozen in liquid nitrogen
for the lipase activity assay. For subcellular fractionation, frozen islets
were resuspended in 6 volumes of homogenization buffer [0.25 mol/l
sucrose, 1 mmol/l dithiothreitol, 1 mmol/l EDTA, 1% phosphatase
inhibitor cocktail (Sigma P5726), 1% protease inhibitor cocktail
(Sigma P8340), pH 7.4] and homogenized by being passed through a
27-gauge needle five times on ice (45). The homogenate was centri-
fuged at 16,000 g, and the resulting supernatant was then centrifuged
at 160,000 g for 1 h at 4°C, yielding cytosol. Because phosphorylated
HSL has higher hydrolytic activity than dephosphorylated protein
(31), protein phosphatase inhibitors were used to maintain protein in
the phosphorylated state. Homogenization buffer was used throughout
the entire fractionation and centrifugation procedures.
Fat tissue preparation and subcellular fractionation. Cytosol was
prepared from perirenal and epididymal fat pads from 200- to 220-g
rats. Whole perirenal and epididymal fat pads were removed, minced,
and then homogenized with 10 strokes in homogenization buffer
containing 20 mmol/l Tris HCl, 0.25 mol/l sucrose, 1 mmol/l EDTA,
1 mmol/l benzamidine, 1% protease inhibitor cocktail, and 1% phos-
phatase inhibitor cocktail, pH 7.4. Postmicrosomal supernatant was
prepared as described above.
Purification of HSL from rat adipose tissue. HSL protein was
purified according to the acid precipitation method of Egan (10). After
chromatography with Phenyl-Sepharose and elution with ethylene
glycol, most hydrolytic activity was in the 45–65% ethylene glycol
elution fractions. A protein of 84 kDa was observed in SDS-PAGE.
About 10% of the final fraction was HSL (data not shown). Peak
activity fractions were pooled and diluted 3.5-fold with the eluting
solution containing 0.05% CHAPS and concentrated in a 15-ml
Amicon ultrafilter using a PM30 membrane. The final solution was
30 times more concentrated than the initial pooled column eluate.
Fresh or once-frozen (70°C) concentrated protein from three sepa-
rate preparations was used for lipase activity experiments. After
purification, 90% of cytosolic HSL activity remained for up to 2
days at 4°C, whereas20–30% activity was lost after freeze-thawing.
Lipase activity assay and protein determination: lipase activity
assay in cell extracts. PNPB, which is a water-soluble lipase substrate,
can be digested by both esterases and lipases. TG is a natural substrate
of lipases. Compared with other substrates, hydrolytic activity against
PNPB is 20-fold greater (20). To differentiate the possible regula-
tory role of LC-CoA role on lipase and esterase activities, both PNPB
and TG were used as substrates. Lipase/esterase activity against PNPB
was determined by measuring the rate of release of p-nitrophenol by
the procedure described by Osterlund et al. (31). LC-CoA esters were
dissolved in H2O. About 6 g of the partially purified protein or 30 g
of islet cytosolic protein (representing 150 islets) were added to 1 ml
of reaction mixture containing 50 mmol/l NaH2PO4 buffer, 0.5
mmol/l PNPB, 1% (vol/vol) acetonitrile, 10% glycerol, and 0.1 mol/l
NaCl, pH 7.25, with or without PP2A. PP2A dephosphorylates HSL.
The reaction was then incubated for 20 min at 30°C. After addition of
10 mol/l Pal-CoA, incubation continued for another 10 min at 37°C.
Hydrolysis was stopped by addition of 3.25 ml of methanol-chloro-
form-heptane (10:9:7 vol/vol/vol), followed by vigorous shaking and
centrifugation at 1,000 g for 1 min. Thereafter, the solution was
incubated at 42°C for 3 min. Activity was measured as absorbance at
400 nm of the supernatant containing p-nitrophenol. One unit of
enzyme activity is equivalent to 1 mol of fatty acid released per
minute at 37°C. Lipase activity against TG was determined by
measuring glycerol in islets homogenate with a commercial kit
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(Sigma). Briefly, partially purified HSL or islet homogenate was
incubated with an emusified mixture of soybean oil at 37°C for 30
min. Islet homogenate without TG addition was blank. The mixture
was then incubated with glycerol measurement reagent at 30°C for
another 15 min. In the reaction, glycerol is phosphorylated by aden-
osine-5-triphosphate (ATP) forming glycerol 1-phosphate (G-1-P)
and adenosine-5-diphosphate (ADP) in a reaction catalyzed by glyc-
erol kinase (GK). G-1-P is then oxidized by glycerol phosphate
oxidase (GPO) to dihydroxyacetone phosphate (DAP) and hydrogen
peroxide (H2O2). Peroxidase (POD) catalyzes the coupling of H2O2
with 4-aminoantipyrine (4-AAP) and sodium N-ethyl-N-(3-sulfopro-
pyl)-m-anisidine (ESPA) to produce a quinoneimine dye that has
absorbance maximum at 540 nm (4).
Lipase activity assay in intact islets. Mouse islets were prepared
and recovered in culture medium overnight as described above. On the
next day, 100 islets were incubated in Krebs-Ringer bicarbonate
buffer (KRB) containing (in mmol/l) 119 NaCl, 4.6 KCl, 5 NaHCO3,
2 CaCl2, 1 MgSO4, 0.15 Na2HPO4, 0.4 KH2PO4, and 20 HEPES and
0.5% BSA, pH 7.4, with different glucose concentrations in the
presence or absence of 0.25 mmol/l FFA (palmitate/oleate 1:1 ratio)
overnight, and KRB buffer was then collected and concentrated to 50
l. Released glycerol was measured using the commercial kit as
described above. Protein was determined by the Lowry method (1),
using bovine serum albumin as standard.
Statistical analysis. Means and standard errors (SE) were calcu-
lated. Student’s t-test for unpaired data or, for multiple comparisons,
one-way ANOVA with Dunnett post testing was used. Differences
were considered significant at P  0.05.
RESULTS
Pal-CoA-stimulated islet lipase activity. Although an inhib-
itory effect of LC-CoA has been reported on adipocyte lipase
activity, its capacity to regulate lipase activity in islets has not
been assessed. To evaluate this, islet cytosol was prepared from
1,500 mouse islets (200 islets were obtained from each
mouse). Lipase activity was measured in the presence of 0–20
mol/l Pal-CoA. Surprisingly, rather than inhibition, Pal-CoA
caused an increase in hydrolytic activity in mouse islets against
PNPB in a concentration-dependent manner (Fig. 1A) and
against TG (Fig. 1B). In addition, islets incubated with 0.25
mmol/l FFA (palmitate/oleate 1:1 ratio) overnight exhibited
increased glycerol release (Fig. 1C).
The stimulatory lipolytic response to LC-CoA in islets, as
opposed to the inhibitory response in fat, could be due to the
expression of different lipases or alternate regulation of the
same lipases. Of note, islet and adipose tissue have different
HSL isoforms, which could vary in response to regulating
factors (22). To further assess this, lipase activities against
PNPB and TG, in the absence and presence of Pal-CoA, were
determined in cytosolic extracts from HSL/ and HSL/
mice islets. Although basal TG lipolysis (Fig. 2B) was reduced
in the HSL/ islets, LC-CoA activation of lipase activity
against both the PNPB (Fig. 2B) and TG (Fig. 2A) substrates
was robust and unaltered in both HSL/ and HSL/ islets.
Clearly, alternate lipase/s contribute, but are unable to com-
pletely normalize, basal TG lipase, as we have previously
reported. Furthermore, it is these alternate lipase/s that are
activated by Pal-CoA in islets.
Pal-CoA inhibits both purified HSL and cytosolic lipase
activities from rat adipose tissue. Considering the potent effect
of Pal-CoA to activate lipase activities in islets, we thought it
was important to confirm the previously reported inhibitory
effect of LC-CoA on lipase activities of adipocytes (18, 39)
using our systems. Lipase activity, in the presence and absence
of Pal-CoA (0–50 mol/l), against PNPB [by partially purified
adipocyte HSL (Fig. 3A) and the adipocyte cytosolic fraction
(Fig. 3C)] and against TG [partially purified adipocyte HSL
only (Fig. 3B)] were assessed. Pal-CoA caused a concentra-
tion-dependent decrease in lipase activity against PNPB in both
preparations (Fig. 3, A and C). For partially purified HSL,
Pal-CoA inhibited hydrolytic activity against both PNPB (Fig.
3A) and TG (Fig. 3B) substrates. Half-maximal inhibition
occurred between 1 and 10 mol/l, and maximum inhibition
was achieved at 50 mol/l Pal-CoA, at which concentration
lipase activity was 70% inhibited (Fig. 3A). For the adipocyte
cytosolic fraction, 1 mol/l Pal-CoA caused a half-maximal
inhibition and 10 mol/l Pal-CoA caused a maximum inhibi-
tion of 50% of total lipase activity (Fig. 3C). Pal-CoA at 10
mol/l was used for further experiments. The results to date
are therefore consistent with a markedly divergent stimulatory
effect of LC-CoA on islet lipase activity and an inhibitory
Fig. 1. Palmitoyl-CoA (Pal-CoA) stimulated islet hydrolytic activity. Activity
assays with mouse islet cytosol against p-nitrophenyl butyrate (PNPB; A) or
triglyceride (TG; B) were performed in the absence or presence of various
concentrations of Pal-CoA (10 M Pal-CoA in B). C: glycerol release from
isolated islets after incubation with 2 or 10 mM glucose in the presence or
absence of 0.25 mmol/l free fatty acid (FA; palmitate/oleate 1:1 ratio). Data are
means 	 SE; n 
 3. *P  0.05, ***P  0.001.
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effect on adipocyte lipase. Furthermore, the stimulatory effect
in islets is not via HSL; whereas the inhibitory effect in
adipocytes occurs at least partly via inhibition of HSL. This
latter finding is consistent with previous reports, which indicate
that LC-CoA inhibits partially purified adipocyte HSL activity
(18, 27, 39).
To determine the effect of LC-CoA on non-HSL lipases in
adipocytes, activities of adipocyte cytosolic fractions from
HSL/ and HSL/ mice adipocytes were assessed. Basal
hydrolytic activity from HSL/ adipocytes against PNPB was
decreased by approximately one-half (Fig. 4A) and against TG
was reduced by 35% (Fig. 4B). Interestingly, Pal-CoA in-
hibited hydrolytic activity against PNPB in both HSL/ and
HSL/ adipose tissue (Fig. 4A) but inhibited lipase activity
against TG lipase only in wild-type adipose tissue (Fig. 4B).
Thus Pal-CoA, in addition to inhibiting esterase and lipase
activities of HSL, can also inhibit activity of alternate ester-
ase/s, but not alternate TG lipase/s.
Pal-CoA regulation and phosphorylation state of the en-
zyme. To determine whether Pal-CoA regulation of lipolysis in
adipose tissue and islets is dependent on the phosphorylation
state of the lipase enzymes, activity of semipurified HSL from
rat adipocytes and the cytosol of islets was measured in the
presence and absence of phosphatase inhibitors PP2A or PP2A
together with PKA. Results demonstrated that preparation of
adipose tissue HSL in the presence of phosphatase inhibitors
increased basal lipase activity more than twofold (Fig. 5A).
Pal-CoA at 10 mol/l reduced lipase activity of the phosphor-
ylated HSL by 60% but had no significant effect on the
dephosphorylated enzyme (Fig. 5A). Consistent with these
findings, the phosphatase PP2A decreased lipase activity by
70%, and 10 mol/l Pal-CoA again had no effect on the
resultant dephosphylated protein (Fig. 5B). Moreover, lipase
activity inhibited by PP2A treatment was partially restored by
exogenous PKA plus ATP following the PP2A treatment (Fig.
5B). The partly rephosphorylated lipase/esterase could then be
inhibited by Pal-CoA (Fig. 5B). Thus Pal-CoA inhibition of
adipose tissue HSL requires the enzyme to be in the most
active phosphorylated state.
PP2A inhibited lipase activity by 50% in islets (Fig. 5C).
Pal-CoA robustly stimulated lipase activity in both mouse (Fig.
5C) and rat (data not shown) islet extracts. Although stimula-
tion was greater in the phosphorylated state, marked stimula-
tion occurred in both the phosphorylated and dephosphorylated
islet extracts (Fig. 5C). Thus lipase enzyme phosphorylation is
not essential for the stimulatory effect of LC-CoA on islet
lipolysis.
ACBP modulation of lipase activity. Protein-protein interac-
tion may enhance enzyme activity of some proteins (25). In
particular HSL activity increases when bound to FABP (17).
To determine whether ACBP affected lipolysis in adipocytes
and islets or was essential for LC-CoA regulation, 1 mol/l
ACBP was added to the hydrolytic activity assay. It was found
Fig. 2. Pal-CoA (10 M) stimulated islet lipase activity in HSL/ and
HSL/ mice against PNPB (A) or TG (B). Data are means	 SE; n
 3. *P
0.05, **P  0.01, ***P  0.001.
Fig. 3. Pal-CoA inhibited rat adipocyte hormone-sensitive lipase (HSL) ac-
tivity in partially purified HSL (A and B) and adipocyte cytosolic extracts (C)
against PNPB (A and C) or TG (B). Data are means 	 SE; n 
 3. **P  0.01,
***P  0.001.
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that ACBP had no effect on adipose tissue HSL/esterase
activity in the absence of added LC-CoA but enhanced the
inhibitory effect of a minimally inhibitory concentration of
Pal-CoA (1 mol/l; Fig. 6A). FABP is reported to bind HSL
(40, 42). This enhanced effect may due to binding HSL and
presenting LC-CoA to regulate lipolysis. In contrast, the stim-
ulatory effect of Pal-CoA (1 mol/l) on islet lipase was
blocked by 1 mol/l ACBP (Fig. 6B). This reversal of LC-CoA
stimulation of lipase activity may have been due to its binding
and removal by ACBP.
DISCUSSION
This investigation into the role of LC-CoA in the regulation
of lipolysis in both adipose and islet tissue not only confirms
the importance of this molecule as a regulator of metabolic
enzymes but also exposes some of the complexity of the
mechanisms involved, which are highly tissue specific. Re-
markably, Pal-CoA inhibited lipase enzyme activity in adipose
tissue, consistent with previous reports (18, 39) but, in contrast,
robustly stimulated it in islets. From experiments utilizing the
HSL/ mouse, it became evident that Pal-CoA inhibition of
TG lipase activity in adipocytes was predominantly due to its
effect on HSL activity but that its stimulatory effect in islets
was via an alternative lipase. Furthermore, its inhibitory effect
was on phosphorylated rather than dephosphorylated HSL,
whereas its stimulatory effect was predominantly independent
of phosphorylation status. ACBP-enhanced effectiveness of
low concentrations of Pal-CoA to inhibit lipase activity could
be due to a protein-protein interaction between ACBP and
adipocyte HSL. In contrast, ACBP-diminished effectiveness of
Pal-CoA to activate lipase enzyme activity in islet cytosolic
fractions may be due to sequestration of free Pal-CoA.
These findings and those of previous studies allow us to
develop an islet -cell/adipocyte model (Fig. 7) that incorpo-
rates the disparate effects of LC-CoA on lipolysis between the
two tissues. In the islet -cell (Fig. 7), elevated glucose
increases intracellular LC-CoA levels by 1) malonyl-CoA
inhibition of FFA oxidation via allosteric inhibition of carnitine
palmitoyltransferase I (5, 35, 38) and 2) increased exogenous
FFA supply to the -cell by glucose and insulin-stimulated
islet lipoprotein lipase (LPL) (6, 32). Furthermore, LC-CoA
enhances its own formation by activating intracellular lipolysis
Fig. 4. Hydrolytic activity measurement in the absence or presence of Pal-
CoA (10 M) in adipose tissue of HSL/ and HSL/ mice against PNPB
(A) or TG (B). Data are means 	 SE; n 
 3. **P  0.01, ***P  0.001.
Fig. 5. Pal-CoA regulation and enzyme phosphorylation state. A: hydrolytic
activity against PNPB of partially purified adipocyte HSL prepared in the
presence or absence of a cocktail of phosphatase inhibitors and incubated in the
presence and absence of Pal-CoA (10 M). B: hydrolytic activity against
PNPB in the presence or absence of Pal-CoA (10 M) of partially purified
adipocyte HSL incubated in the presence or absence of 30 nM protein
phosphatase 2A (PP2A) or 30 nM PP2A followed by 5 nM PKA. C: hydrolytic
activity in the absence or presence of Pal-CoA (10 M) of islet cytosol
incubated with or without 30 nM PP2A. Values represent means 	 SE; n 
 3.
*P  0.05, **P  0.01, ***P  0.001.
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of complex lipids via non-HSL lipases, thus enhancing FFA
supply for LC-CoA synthesis from endogenous sources. The
resultant amplification of -cell LC-CoA levels by elevated
glucose augments the effect of the KATP-dependent pathway of
glucose-stimulated insulin secretion to induce insulin exocyto-
sis. In the adipocyte (Fig. 7), glucose and insulin also contrib-
ute to elevated intracellular LC-CoA by activation of adipose
tissue LPL, which provides increased exogenous FFA supply
(14). Inhibition of FFA oxidation by malonyl-CoA may also
contribute. Recent data support a major role for cytosolic
LC-CoA in explaining the regulation of oscillatory lipolysis
(13). The increased LC-CoA together with insulin inhibit
adipocyte lipolysis. Insulin prevents the HSL activity by pre-
venting its phosphorylation (20), and LC-CoA inhibits HSL
that is already phosphorylated. Thus these disparate tissue
effects of LC-CoA work in concert, promoting highly effective
inhibition of adipocyte FFA release.
Considering the well-established effect of feeding to inhibit
lipolysis in adipose tissue, at first it seems counterintuitive that
such conditions should enhance lipolysis in islets. It is not
difficult to reconcile these findings, however, when it is re-
membered that the role of lipolysis is very different between
the two tissues. In support of the findings in islet tissue, it has
previously been shown that elevated glucose increases lipolysis
rates in whole rat (29) and mouse (33) islets. Furthermore, this
effect is evident in both wild-type and HSL/ mouse islets
(33), consistent with the finding that HSL is not necessary for
LC-CoA activation of lipolysis in islets. The finding that
elevated glucose also induces the expression of HSL in clonal
-cells (45) may be important, but it is still unclear whether
HSL has a significant role in the islet. The novel islet lipase/s
in islets still needs to be identified and will allow further
analysis of the mechanisms by which LC-CoA is stimulatory in
this tissue.
LC-CoA inhibition of HSL activity was clearly shown to
depend on HSL phosphorylation. Previous data demonstrated
that lipase preparations activated by PKA phosphorylation
were four to six times more sensitive to inhibition by oleoyl-
CoA than were nonactivated preparations (39). Our data are
therefore consistent with this conclusion.
Protein-protein interaction of HSL with FABP in vitro and in
vivo has also been documented (17, 41). It is therefore possible
that LC-CoA via ACBP/HSL/LC-CoA or FABP/HSL/LC-CoA
complex is involved in the inhibitory effect on HSL. In this
Fig. 6. Influence of acyl-CoA-binding protein (ACBP) on lipase activity in
adipocytes and islets. Partially purified fat HSL (A) or islet cytosolic extract (B)
activity against PNPB was measured in the absence or presence of 1 M
Pal-CoA, 1 M ACBP, or 1 M ACBP  1 M Pal-CoA. Values represent
means 	 SE; n 
 3. *P  0.05, **P  0.01.
Fig. 7. Integrative model showing the synergis-
tic end effect of disparate actions of long-chain
CoA (LC-CoA) on lipolysis regulation in
-cells and fat cells. High glucose and exoge-
nous fatty acids (FFA) increase cytosolic LC-
CoA accumulation in -cells. LC-CoA stimu-
lates lipolysis, which essentially amplifies its
own levels and its capacity to signal for en-
hanced insulin secretion. Insulin, in turn, po-
tently inhibits adipocyte lipolysis by 1) prevent-
ing PKA phosphorylation, which activates HSL
and 2) LC-CoA inhibition of already phosphor-
ylated HSL. Insulin increases LC-CoA via its
effect to increase adipocyte LPL activity, thus
increasing the exogenous FFA supply to the
cell. The end effect of the initiating event of
elevated glucose is promotion of adipocyte TG
storage. Mal-CoA, malonyl-CoA; LPL, lipopro-
tein lipase; -OX, -oxidation; CPT1, carnitine
palmitoyltransferase I; -GP, -glycerolphos-
phate.
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study, ACBP enhanced the inhibitory effect of Pal-CoA, sug-
gesting that ACBP, at least in part, could be involved in the
inhibitory regulation of LC-CoA on HSL in fat tissue. The
stimulatory effect of LC-CoA was blocked by ACBP in islets,
suggesting that ACBP and non-HSL lipase interaction is un-
likely to be involved in the LC-CoA activation of these
lipase/s. In islets, ACBP presumably removed LC-CoA from
lipases, preventing activation by the LC-CoA.
In conclusion, we have demonstrated important, but diver-
gent, effects of LC-CoA on the regulation of lipolysis in
adipocytes and islets. LC-CoA inhibits adipocyte lipolysis and
activates lipolysis in islets. These results increase the evidence
implicating LC-CoA not only as an important intermediate of
lipid metabolism but also as a major regulator of cellular
function. The disparate tissue effects may be due to differences
in the dominant lipase enzymes (isoenzymes) present. Further-
more, the inhibitory and/or stimulatory effects of LC-CoA can
be influenced by enzyme phosphorylation status and the pres-
ence of acyl-CoA-binding proteins such as ACBP and FABP.
Finally, the results add to the increasing evidence indicating
that lipolysis is a highly regulated and important process in
islet -cell function.
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